Allogene Therapeutics, Inc.
← Back to ALLO Overview

Allogene Therapeutics, Inc. (ALLO)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-3.39

Financial Fundamentals

ALLOQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2017-12-31-137535.24
2018-03-31-105.93
2018-06-30-5.25
2018-09-30-16.45
2018-12-31-18.20
2019-03-31-22.45
2019-06-30-17.28
2019-09-30-13.63
2019-12-31-11.20
2020-03-31-9.72
2020-06-30-20.20
2020-09-30-18.13
2020-12-31-11.91
2021-03-31-35.30
2021-06-30-12.30
2021-09-30-11.27
2021-12-31-6.91
2022-03-31-4.07
2022-06-30-5.48
2022-09-30-4.66
2022-12-31-2.38
2023-03-31-1.82
2023-06-30-2.30
2023-09-30-2.14
2023-12-31-1.57
2024-03-31-2.88
2024-06-30-1.66
2024-09-30-2.19
2024-12-31-1.90
2025-03-31-1.30
2025-06-30-1.23
2025-09-30-1.63
2025-12-31-2.01
2026-03-31-3.39

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.